New patent for Boehringer Ingelheim drug GILOTRIF

March 11, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for GILOTRIF Gilotrif is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…

The post New patent for Boehringer Ingelheim drug GILOTRIF appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.